These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2099838)

  • 1. Chemotherapy and hormonal therapy in stage III disease; inflammatory breast cancer.
    Ragaz J
    Curr Opin Oncol; 1990 Dec; 2(6):1068-87. PubMed ID: 2099838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical treatment of breast carcinoma].
    Rosso R; Gardin G
    Ann Ital Chir; 1991; 62(5):467-77. PubMed ID: 1801625
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic therapy of breast cancer--1985.
    Vogel CL
    Semin Oncol Nurs; 1985 Aug; 1(3):189-94. PubMed ID: 3849050
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
    Petit T; Claude L; Carrie C
    Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant systemic therapy of breast cancer.
    Lippman ME
    Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
    [No Abstract]   [Full Text] [Related]  

  • 8. Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.
    O'Shaughnessy JA; Cowan KH; Wilson W; Bryant G; Goldspiel B; Gress R; Nienhuis AW; Dunbar C; Sorrentino B; Stewart FM
    Hum Gene Ther; 1993 Jun; 4(3):331-54. PubMed ID: 8338880
    [No Abstract]   [Full Text] [Related]  

  • 9. Conservation treatment intensified with tamoxifen and CAF chemotherapy for subareolar breast cancers.
    Ogawa Y; Nishioka A; Inomata T; Tsuboi N; Hayase N; Fukumoto M; Yoshida S; Tohchika N; Tanaka Y; Kumon M
    Oncol Rep; 1998; 5(6):1337-41. PubMed ID: 9769365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on cancer chemotherapy: general considerations and breast cancer. Part II.
    Wright JC
    J Natl Med Assoc; 1985 Sep; 77(9):691-703. PubMed ID: 3903172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 12. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
    Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
    Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
    Wu K; Brown P
    J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment decisions in breast cancer.
    Gore SM; Langlands AO; Spiegelhalter DJ; Stewart HJ
    Recent Results Cancer Res; 1988; 111():149-70. PubMed ID: 3051226
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
    Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Sniecinski I
    Cancer; 1994 Jan; 73(1):125-34. PubMed ID: 7903906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is the benefit of adjuvant therapy in breast cancer?].
    Sauer H
    Fortschr Med; 1992 Nov; 110(30):16-8, 20. PubMed ID: 1468737
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy for breast cancer: the French PEGASE experience.
    Roche H; Viens P; Biron P; Lotz JP; Asselain B;
    Cancer Control; 2003; 10(1):42-7. PubMed ID: 12598854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Brown RJ; Davidson NE
    Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.